L8 Inflammation and Pregnancy Flashcards

1
Q

Why is controlled heterogenous inflammation crucial during gestation?

A
  • Need to carefully modulate immune responses at different stages to facilitate gestation and parturition
  • e.g. Proper implantation and placentation require proinflammatory conditions (allowing invasion and remodelling of maternal tissue)
  • e.g. Fetal growth requires anti-inflammatory conditions (preventing graft rejection of the fetus)
  • e.g. Parturition requires pro-inflammatory conditions to evict the baby
  • Various adverse outcomes come about when these inflammatory programmes go wrong
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give 5 adverse pregnancy outcomes caused by disrupted inflammation:

A
  • Preeclampsia
  • Preterm birth
  • Miscarriage
  • Stillbirth
  • Fetal growth restriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two types of immune response?

A
  • Innate immunity (rapid with no memory) -> macrophages, dendritic cells, NK cells, neutrophils and more
  • Adaptive immunity (slower with specificity to insult) -> B cells producing Abs, T cells differentiating
  • Some cells play a role in both (e.g. types of NK and T cells)
  • The two systems support each other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are naive T-cells differentiated?

A
  • Antigen-presenting cells recognise DAMPs/PAMPs/toll-like receptors of pathogens -> engulfed with antigen presented at surface
  • Stimulates differentiation of naive T cells in coordination with cytokines and other costimulatory signals
  • Key lines: Th1, Th2, Th17 and Treg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the cytokines required for differentiation of key T-cell lines?

A
  • Th1 (pro-inf): exogenous IL-12, IFNy from self
  • Th2 (anti-inf): exogenous IL-4
  • Th17 (similar behaviour to Th1): exogenous IL-6, IL-23, TGF-B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What types of inflammatory cells are important immediately following implantation (including proportion):

A
  • 70% NK
  • 20-25% Macrophages
  • 1.7% dendritic cells
  • ~3 - 10% T cells
  • These populations have an active role in implantation, placentation and immune tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What cytokines and dendritic cells are part of the pro-inflammatory conditions during implantation and what is their general function?

A
  • Endometrial stroma and infiltrating inflammatory cells release: IL-1, IL-8, IL-15, GM-CSF, CXCL1, CCL4
  • CD11c+ dendritic cells are crucial
  • These cytokines facilitate receptive conditions in the endometrium (expression, transport and modification to adhesion molecules promoting and accelerating blastocyst attachment)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Th1 dominance promote blastocyst attachment and invasion?

A
  • Transfer and expression of new adhesion molecules to cell surface of uterine lumen
  • Removal of mucin layer -> promoting blastocyst adhesion
  • Increasing affinity for adhesion molecules like L-selectin on uterine epithelium
  • Once attached, blastocysts stimulated to release MMPs -> degrading matrix and allowing invasion (inflammatory-mediated response)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 3 key components of Th2 dominance during gestation and what are their general roles?

A
  • Macrophages, dNK cells and T-reg cells -> antiinflammatory, Th2 dominant environment from weeks 13 to 27
  • M2 type macrophages -> tissue renewal during placental development, breaking down apoptotic trophoblasts to prevent release of paternal antigens
  • dNKs interact with macrophages (CD14+) and induce generation of T-reg cells
  • T-reg cells are crucial for tissue repair (anti-inf, anti-apoptotic); also preventing Teff immune response against paternal antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What role do T-reg cells have in facilitating new pregnancies after birth?

A
  • Capacity for memory
  • Systematically raised in the endometrium during the first pregnancy against paternal antigens of the fetus
  • Some T-reg cells remain after birth, and will accumulate with each subsequent pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What role do Th17-type cells have during fetal development?

A
  • This period is generally Th2-dominant and anti-inflammatory, but Th17 cells have a pro-inflammatory phenotype
  • This small population expands during pregnancy and is thought to be important for protecting against microbial infection at the maternal-fetal interface (under regulation by T-reg cells)
  • As such, an imbalance between these two populations is associated with various pathologies (spontaneous abortion, pre-eclampsia, preterm birth)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What soluble factors maintain Th2 type inflammation and where are they secreted?

A
  • Decidual M2 macrophages: IL-10, TGF-B, IDO
  • Decidual gamma-delta T cells: IL-10, TGF-B and PIBF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What fetal antigens maintain the Th2 type inflammation and how do they achieve this?

A
  • HLA-E
  • HLA-G
  • Both expressed on trophoblast cells -> interact with inhibitory receptors on NK cells and T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is NF-kB signalling induced at the end of pregnancy and why is it important?

A
  • Endogenous damage-associated molecular patterns (DAMPs) and surfactant protein A (maturing fetal lung) produced at end of pregnancy -> activation of NF-kB signalling via TLR-4 activation
  • Leads to switch back to Th1-dominance and production of pro-inflammatory cytokines
  • Causes influx of immune cells into myometrium which are involved in initiating contractions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 3 effects of trophoblast cells on immunological milieu at the implantation site?

A
  • Recruitment of peripheral NK cells and monocytes, Treg cells etc (via chemokines and cytokines) to boost the existing immune population at the implantation site
  • Immune cell education to tailor their phenotypes in supporting pregnancy
  • Environmental sensing to protect against external threat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do trophoblasts recruit immune cells to the implantation site?

A
  • Secretion of cytokines
  • e.g. CXCL12, CXCL8/IL-8, TGF-B, CCL1
17
Q

How do trophoblasts ‘educate’ the immune milieu at the implantation site?

A
  • Specific cytokines influence different immune populations
  • e.g. IL-15 and TGF-B differentiate the decidual NK phenotype from peripheral NKs
  • e.g. M-CSF, IL-10 differentiate M2-like macrophages from CD14+ monocytes (note that they retain C14 expression so are still able to secrete immunomodulatory cytokines like TGF-B, IFNs)
18
Q

How do trophoblasts sense environmental threats during immunoregulatory activity?

A
  • Sensing via expression of receptors like TLRs, NOD-like receptors (NLRs)
  • Able to recognise DAMPs (from dying tissue) and PAMPs (from pathogens) allowing a response to be mounted against potential threats
19
Q

What 3 hormones have a key role in immunoregulation during pregnancy?

A
  • Progesterone
  • Oestrogen
  • Oxytocin
20
Q

How does progesterone act as an immunomodulator? (5 points)

A
  • Blocks lymphocyte proliferation and alters antibody production in existing B lymphocytes
  • Prolonging allograft survival
  • Reduces production of proinflammatory cytokines of macrophages
  • Upregulates TLR-4 expression and suppresses TLR-2 response to intrauterine infection
  • Inhibits MMP1 and MMP3 expression in decidual cells
21
Q

How is progesterone affected during pathological intrauterine inflammation?

A
  • Functional withdrawal
  • Diminishing immunomodulatory effect
  • Big link between infection and miscarriage
22
Q

What are the 2 immunomodulatory effects of oestrogen during pregnancy?

A
  • Inhibits Th1 proinflammatory cytokines (IL12, TNF-a, IFN-y)
  • Stimulates Th2 antiinflammatory cytokines (IL10, IL4, TGF-B)
23
Q

How is oxytocin involved in immune response during parturition?

A
  • Oxytocin receptor upregulated by CEBP, NF-kB -> these TFs are activated by proinflammatory cytokines
  • Potentiating oxytocin action on labour
24
Q

How is maternal tolerance of the fetus maintained? (Overview with 5 examples)

A
  • Broadly speaking, tolerance is achieved by restriction and modulation of leukocytes at the maternal-fetal interface
  • Antiinflammatory cytokines (IL-10, TGF-B) at interface induce differentiation of circulating immune cells into M2 type macrophages and Treg cells
  • Synctiotrophoblasts secrete exosomes containing TRAIL and Fas death ligands -> triggering apoptosis of leukocytes
  • Lack of HLA expression by STB
  • Placental EVTs express HLA-G which binds to dNK inhibitory receptors
  • M2 macrophages release IDO -> hinders T cell activation and phagocytosis of apoptotic trophoblasts
25
Q

How does HLA matching influence viability?

A
  • Category 1: Low-level matching between maternal and fetal HLA 1 antigen -> succesful pregnancy
  • Category 2: High-level matching -> fetal loss, women with recurrent spontaneous abortion
26
Q

How common is preeclampsia:

A
  • Presents in ~7% of pregnancies
  • Leading cause of maternal-perinatal morbidity and mortality
27
Q

Clinical features of PE:

A
  • Hypertension
  • Proteinuria
  • HELLP (haemolysis, elevated liver enzymes, low platelets)
  • Visual disturbances
28
Q

Outline the pathogenesis of PE and how immune imbalance is involved:

A
  • Failure of trophoblast and immune cells to remodel spiral arteries into high-capacity, low resistance vessels due to disruption by pro-inf DC, NK and Th cells
  • Results in a breakdown of placental perfusion and placental ischaemia (i.e. not enough blood) -> hypoxia induces production of inflammatory modulators and antiangiogenic factors via presentation of fetal antigens on apoptotic trophoblasts -> vascular dysfunction in placenta and peripheral vessels
  • Circulating placental factors cause endothelial dysfunction and oxidative stress -> further contribution to hypertension and multiorgan dysfunction
29
Q

How are the spiral arteries remodelled during placentation?

A
  • Trophoblasts and immune cells secrete proteases and angiogenic factors
30
Q

How is late-onset PE different from typical pathology?

A
  • Spiral artery remodelling occurs normally, but placental needs eventually exceed uterine perfusion capacity
  • Results in hypoxia and consequent inflammation, eventual hypertension and widespread effects
31
Q

Link between PE and postpartum inflammation:

A
  • Immune memory of immune response to placental ischaemia
32
Q

What are HLAs and where are they expressed in the fetus?

A
  • Highly genetically diverse system of antigen (human leukocyte antigen)
  • Expressed primarily on extravillous trophoblasts
  • Pivotal to immune tolerance
  • Three classes: Class I divided into Ia (A, B, C) and Ib (E, F, G)
33
Q

Outline the mechanism through which low level HLA matching promotes successful pregnancy:

A
  • Fetal antigens processed and presented by maternal CD8+ T cells -> differentiate int CD8TFLCs
  • CD8TFLCs interact w/ maternal B cells, inducing formation of plasma B cells
  • These produce IgG Abs specific to the fetal HLA I -> blocked from interaction with CD8+ to produce cytotoxic T cells
  • Trophoblasts protected and pregnancy preserved
34
Q

Outline the mechanism through which high level HLA matching promotes spontaneous abortion:

A
  • High level HLA matching alters the processing of fetal HLA by CD8+, so IgG Abs are not raised against them in differentiated plasma B cells
  • Instead, the processing and presentation of fetal HLA activates CD8+ into CD8+ cytotoxic cells -> release of cytolytic mediators (perforin, granzymes)
  • Leads to trophoblast cell death, initiating a cascade into spontaneous abortion
35
Q

How have therapeutic approaches addressed the issue of high-level HLA matching?

A
  • The mother is injected with paternal lymphocytes in advance of pregnancy
  • This induces the low-level matching pathway raising antibodies against paternal HLA resulting in protection from cytotoxic CD8+ cells